Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

New compounds may help treat heart disease by activating specific potassium channels.

5-ARI therapy may help prevent prostate cancer progression.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Baricitinib is a promising treatment for alopecia areata.

Five FDA-approved drugs may help block COVID-19 virus entry.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Pranlukast and mirabegron may work as new diabetes drugs.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Baricitinib is effective and safe for treating severe alopecia areata.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.